Last reviewed · How we verify

NCT06213194

The Effects of Executive Functions and Social Cognition on Mental Health

Completed NA Results posted Last updated 17 March 2025
What this trial tests

NA trial testing MindZone in Autism or Autistic Traits in 178 participants. Completed in 21 October 2024.

Timeline
20 May 2024
Primary endpoint
10 October 2024
21 October 2024

Quick facts

Lead sponsorIbn Haldun University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment178
Start date20 May 2024
Primary completion10 October 2024
Estimated completion21 October 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ibn Haldun University

Who can join

Adults 18 to 40, any sex, with Autism or Autistic Traits or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Depression_1 Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Depression Anxiety Stress Scale 21 will be used to measure depression outcome. Higher scores mean higher depressive symptoms. The minimum and maximum scores are 0-21, respectively.

Pretest
GroupValue95% CI
Experimental Group9.87± 3.72
Control Group10.24± 4.02
Posttest
GroupValue95% CI
Experimental Group7.65± 2.57
Control Group9.15± 4.13
Anxiety Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Depression Anxiety Stress Scale - 21 will be used to measure anxiety outcome. Higher scores mean higher anxiety symptoms. The minimum and maximum scores are 0-21, respectively.

Pretest
GroupValue95% CI
Experimental Group9.42± 3.70
Control Group9.44± 3.94
Posttest
GroupValue95% CI
Experimental Group6.74± 2.94
Control Group8.03± 4.20
Stress Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Depression Anxiety Stress Scale - 21 will be used to measure stress outcome. Higher scores indicate higher stress. The minimum and maximum scores are 0-21, respectively.

Pretest
GroupValue95% CI
Experimental Group7.61± 3.98
Control Group6.32± 3.98
Posttest
GroupValue95% CI
Experimental Group5.58± 3.56
Control Group7.79± 4.05
Cognitive Flexibility - Errors Rate Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Cognitive flexibility - Errors Rate will be measured by the Wisconsin Card Sorting Task. Higher errors indicate lower scores on cognitive flexibility. During the task, 400 cards in two blocks are displayed on the screen and the sorting rule changes after every 10 cards. Maximum score is 400 and minimum score is 0.

Pretest
GroupValue95% CI
Experimental Group21± 10
Control Group22± 4
Posttest
GroupValue95% CI
Experimental Group40± 20
Control Group37± 15
Working Memory - Errors Rate Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Working memory - Errors Rate will be measured by the N-back task. Higher errors indicate lower working memory scores. Maximum score is 400, minimum score is 0

Pretest
GroupValue95% CI
Experimental Group20.65± 9.19
Control Group15.09± 11.94
Posttest
GroupValue95% CI
Experimental Group13.13± 8.59
Control Group10.50± 7.55
Inhibition - Errors Rate Primary · Pre-test (baseline), Post-test (immediately after the intervention)

Inhibition - Errors Rate will be measured by Go/No Go task. Higher scores indicate lower inhibition. There are 12 blocks of 50 trials each. Commission errors (i.e., incorrectly responding to no-go trials) were measured. Maximum score is 600. Minimum score is 0.

Pretest
GroupValue95% CI
Experimental Group5.48± 6.59
Control Group3.24± 5.18
Posttest
GroupValue95% CI
Experimental Group4.48± 3.37
Control Group3.85± 3.21
Cognitive Empathy Secondary · pretest and posttest conditions

The Eyes Test were used to measure cognitive empathy. Higher scores indicate higher cognitive empathy scores. Maximum score is 36, minimum score is 0.

Pretest
GroupValue95% CI
Experimental Group24.45± 3.88
Control Group25.65± 3.27
Posttest
GroupValue95% CI
Experimental Group25.39± 4.29
Control Group26.59± 3.44
Self-Assessment Manikin for Affective Empathy Secondary · pretest and posttest conditions

Self Assessment Manikin was used to measure affective empathy. Valence scores for each emotion were obtained by summing responses for all images. The maximum score is 270, and the minimum score is 30. Higher scores indicate better affective empathy.

Pretest
GroupValue95% CI
Experimental Group130.16± 20.43
Control Group119.35± 16.88
Posttest
GroupValue95% CI
Experimental Group126.16± 12.90
Control Group117.38± 16.61

Sponsor's own description

The objective of this study is to analyze the effects of executive functions (EFs) and social-cognitive abilities on the associations between autistic traits and mental health indicators (depression, anxiety, and stress). Moreover, the study will produce online training modules for executive functions and social cognition, aimed at reducing the likelihood of adverse mental health outcomes in individuals with and without elevated autistic traits. Therefore, four main hypotheses will be addressed: 1. Revealing the mediating role of executive functions (cognitive flexibility, inhibitory control, and working memory) will help predict the association between autistic traits and mental health symptoms (anxiety, depression, and stress). 2. Revealing the mediating role of social cognitive skills (cognitive empathy and affective empathy) will help predict the association between autistic traits and mental health symptoms (anxiety, depression, and stress). 3. Online training in executive functions and social cognitive skills will help develop executive functions (working memory, inhibitory control, and cognitive flexibility) and social cognitive skills (cognitive empathy and affective empathy) in the current sample. 4. Online training in executive functions and social cognitive skills will promote mental health by reducing distress, depression, and anxiety symptoms in the current sample. Participants will be between the ages of 18-35 because previous findings indicate that the age of onset of various mental health problems is between the ages of 17 and 35. Participants will be randomly assigned to the experimental and control groups. Using a longitudinal design including pre-test, post-test, and follow-up conditions to test the effectiveness of combined EFs and social cognition online training for mental health symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism or Autistic Traits

Currently open trials in the same condition.

Other Ibn Haldun University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06213194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing